Radioimmunoassay

With reference to the article by Rebecca Krumm in the May 16, 1994, issue of The Scientist on radioimmunoassays [page 17]: A possible quantitative measure of the current use of radioimmunoassay (RIA) might be the data prepared by the Institute for Scientific Information on the number of references, over the years, to "preparation of iodine-131- labeled human growth hormone of high specific activity." This was a preliminary report o

Written byFrederick Greenwood
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

With reference to the article by Rebecca Krumm in the May 16, 1994, issue of The Scientist on radioimmunoassays [page 17]: A possible quantitative measure of the current use of radioimmunoassay (RIA) might be the data prepared by the Institute for Scientific Information on the number of references, over the years, to "preparation of iodine-131- labeled human growth hormone of high specific activity."

This was a preliminary report of the method published by W.M. Hunter and F.C. Greenwood in Nature, 914:495-6, 1962. This report and the full report, published by F.C. Greenwood, Hunter, and S. Glover, Biochemical Journal, 89:114-23, 1963, were both named Citation Classics. In Current Contents No. 26, June 26, 1989, page 16, I tried to explain the apparent paradox in an article entitled "Longevity of immunochemical methods that work."

I spent much of my scientific life in England looking at hormone levels, first in urine and then ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies